KD Logo

NVCR’s latest rating updates from top analysts.

In a filing, NovoCure Ltd revealed its Chief Operating Officer GROENHUYSEN WILHELMUS CM unloaded Company’s shares for reported $19484.0 on Mar 04 ’24. In the deal valued at $16.01 per share,1,217 shares were sold. As a result of this transaction, GROENHUYSEN WILHELMUS CM now holds 251,235 shares worth roughly $3.08 million.

Then, Leonard Frank X sold 840 shares, generating $13,448 in total proceeds. Upon selling the shares at $16.01, the EVP, Pres., Novocure Oncology now owns 160,098 shares.

Before that, GROENHUYSEN WILHELMUS CM sold 2,107 shares. NovoCure Ltd shares valued at $33,769 were divested by the Chief Operating Officer at a price of $16.03 per share. As a result of the transaction, GROENHUYSEN WILHELMUS CM now holds 252,452 shares, worth roughly $3.09 million.

A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who decreased its forecast for the stock in late August from “a Buy” to “a Neutral”. Piper Sandler also remained covering NVCR and has increased its forecast on August 08, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. SVB Securities started covering the stock on August 04, 2023. It rated NVCR as “an Outperform”.

Price Performance Review of NVCR

On Tuesday, NovoCure Ltd [NASDAQ:NVCR] saw its stock fall -4.38% to $12.24. Over the last five days, the stock has gained 1.53%. NovoCure Ltd shares have fallen nearly -18.02% since the year began. Nevertheless, the stocks have fallen -81.43% over the past one year. While a 52-week high of $83.60 was reached on 03/08/24, a 52-week low of $10.87 was recorded on 04/23/24. SMA at 50 days reached $14.29, while 200 days put it at $17.40. A total of 1.02 million shares were traded, compared to the trading of 1.07 million shares in the previous session.

Levels Of Support And Resistance For NVCR Stock

The 24-hour chart illustrates a support level at 12.08, which if violated will result in even more drops to 11.92. On the upside, there is a resistance level at 12.53. A further resistance level may holdings at 12.82. The Relative Strength Index (RSI) on the 14-day chart is 40.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.64%. Stochastics %K at 24.85% indicates the stock is a holding.

Most Popular

[the_ad id="945"]